Biotech in 2019: Gene Therapies, Cancer Immunotherapies, and mRNA Investing in early-stage biotechnology companies requires great skill and patience (luck is always helpful as well). 10 MIN READ 12.4.2018
Avoiding Wild Wall Street Speculative Stocks The last thing momentum-chasing investors care about is valuations. 7 MIN READ 06.11.2018
Neon Therapeutics Files for $100 Million IPO for Immuno-Oncology Pipeline Therapies based on neoantigens --tumor-specific immune targets on the surface of cancer cells. 2 MIN READ 06.1.2018
